-
EP0567094
European procedure
Extract from the Register of European Patents
EP About this file: EP0567094
| EP0567094 - Hydrazoadenosines [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 07.01.2000 Database last updated on 18.03.2026 | Most recent event Tooltip | 20.04.2000 | Lapse of the patent in a contracting state | published on 07.06.2000 [2000/23] | Applicant(s) | For all designated states Discovery Therapeutics, Inc. 2028 Dabney Road - Suite E 17 Richmond Virginia 23230-3311 / US | [N/P] |
| Former [1995/11] | For all designated states Discovery Therapeutics, Inc. 2028 Dabney Road - Suite E 17 Richmond, Virginia 23230-3311 / US | ||
| Former [1993/43] | For all designated states WHITBY RESEARCH, Inc. 2801 Reserve Street Richmond, Virginia 23220 / US | Inventor(s) | 01 /
Olsson, Ray A. c/o Whitby Research, Inc., 2801 Reserve Street Richmond, Virginia 23220 / US | 02 /
Thompson, Robert D. c/o Whitby Research, Inc., 2801 Reserve Street Richmond, Virginia 23220 / US | [1993/43] | Representative(s) | SSM Sandmair Patentanwälte Rechtsanwalt Partnerschaft mbB Joseph-Wild-Straße 20 81829 München / DE | [N/P] |
| Former [1995/11] | Schwabe - Sandmair - Marx Stuntzstrasse 16 D-81677 München / DE | ||
| Former [1993/43] | Sandmair, Kurt, Dr. Dr. Patentanwälte Schwabe, Sandmair, Marx Stuntzstrasse 16 D-81677 München / DE | Application number, filing date | 93106460.4 | 21.04.1993 | [1993/43] | Priority number, date | US19920873440 | 24.04.1992 Original published format: US 873440 | [1993/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0567094 | Date: | 27.10.1993 | Language: | EN | [1993/43] | Type: | A3 Search report | No.: | EP0567094 | Date: | 30.03.1994 | Language: | EN | [1994/13] | Type: | B1 Patent specification | No.: | EP0567094 | Date: | 03.03.1999 | Language: | EN | [1999/09] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 11.02.1994 | Classification | IPC: | C07H19/16, A61K31/70 | [1993/43] | CPC: |
C07H19/16 (EP,US);
A61P43/00 (EP);
A61P9/08 (EP);
A61P9/10 (EP)
| Designated contracting states | BE, DE, FR, GB, IT [1993/43] | Title | German: | Hydrazoadenosinen | [1993/43] | English: | Hydrazoadenosines | [1993/43] | French: | Hydrazoadénosines | [1993/43] | Examination procedure | 21.09.1994 | Examination requested [1994/47] | 20.06.1996 | Despatch of a communication from the examining division (Time limit: M04) | 21.10.1996 | Reply to a communication from the examining division | 30.10.1996 | Despatch of a communication from the examining division (Time limit: M06) | 29.04.1997 | Reply to a communication from the examining division | 08.07.1997 | Despatch of a communication from the examining division (Time limit: M06) | 18.12.1997 | Reply to a communication from the examining division | 19.02.1998 | Despatch of communication of intention to grant (Approval: No) | 18.08.1998 | Despatch of communication of intention to grant (Approval: later approval) | 26.08.1998 | Communication of intention to grant the patent | 27.10.1998 | Fee for grant paid | 27.10.1998 | Fee for publishing/printing paid | Opposition(s) | 04.12.1999 | No opposition filed within time limit [2000/08] | Fees paid | Renewal fee | 24.03.1995 | Renewal fee patent year 03 | 25.03.1996 | Renewal fee patent year 04 | 24.03.1997 | Renewal fee patent year 05 | 26.03.1998 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | BE | 03.03.1999 | [2000/23] | Documents cited: | Search | [X] R.J.HASLAM ET AL.: "Inhibition of Adenylate Cyclase by Adenosine Analogues in Preparations of Broken and Intact Human Platelets.", THE BIOCHEMICAL JOURNAL, vol. 176, no. 1, 1978, LONDON, pages 83 - 95 [X] 1,9,10 * abstract * *page 86, line 14, 2-hydrazinoadenosine* | [PX] K.NIIYA ET AL.: "2-(N'-Aralkylidenehydrazino)adenosines: Potent and Selective Coronary Vasodilators.", JOURNAL OF MEDICINAL CHEMISTRY, vol. 35, no. 24, 1992, WASHINGTON US, pages 4562 - 4566, XP000918386, DOI: doi:10.1021/jm00102a008 [PX] 1-10 * the whole document * DOI: http://dx.doi.org/10.1021/jm00102a008 | [DA] J.E.FRANCIS ET AL.: "Highly Selective Adenosine A2 Receptor Agonists in a Series of N-Alkylated 2-Aminoadenosines.", JOURNAL OF MEDICINAL CHEMISTRY, vol. 34, no. 8, 1991, WASHINGTON US, pages 2570 - 2579, XP002038621, DOI: doi:10.1021/jm00112a035 [DA] 1,9,10 * the whole document * DOI: http://dx.doi.org/10.1021/jm00112a035 | [DA] M.UEEDA ET AL.: "2-Alkoxyadenosines: Potent and Selective Agonists at the Coronary Artery A2 Adenosine Receptor.", JOURNAL OF MEDICINAL CHEMISTRY, vol. 34, no. 4, 1991, WASHINGTON US, pages 1334 - 1339, XP002225574, DOI: doi:10.1021/jm00108a014 [DA] 1,9,10 * the whole document * DOI: http://dx.doi.org/10.1021/jm00108a014 | [X] J.A.MONTGOMERY ET AL.: "2-Substituted Derivatives of 9-alpha-D-Arabinofuranosyladenine and 9-alpha-D-Arabinofuranosyl-8-azaadenine.", JOURNAL OF MEDICINAL CHEMISTRY, vol. 20, no. 3, 1977, WASHINGTON US, pages 401 - 404 [X] 1 *page 401, compound 11* |